Company
Latigo Biotherapeutics, Inc.
Public · LTGOUnited States
Latigo Biotherapeutics is a clinical-stage biopharmaceutical company developing non-opioid pain medicines designed to stop pain transmission without addiction risk.
Latigo Biotherapeutics, Inc. is a publicly traded company, based in the United States. It trades under the ticker LTGO. Leadership tracked by CEOInsider includes Todd Smith (CEO).
Leadership
Current